Oracle Middleware Common Libraries and Tools 12.2.1.3.0/12.2.1.4.0 Third Party Patch input validation
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 9.6 | $5k-$25k | 0.00 |
Summary
A vulnerability was found in Oracle Middleware Common Libraries and Tools 12.2.1.3.0/12.2.1.4.0. It has been classified as very critical. This affects an unknown function of the component Third Party Patch. The manipulation leads to an unknown weakness. This vulnerability is uniquely identified as CVE-2021-42575. The attack is possible to be carried out remotely. No exploit exists. Upgrading the affected component is recommended.
Details
A vulnerability was found in Oracle Middleware Common Libraries and Tools 12.2.1.3.0/12.2.1.4.0 (Middleware) and classified as very critical. This issue affects an unknown code block of the component Third Party Patch. Using CWE to declare the problem leads to CWE-20. The product receives input or data, but it does not validate or incorrectly validates that the input has the properties that are required to process the data safely and correctly. Impacted is confidentiality, integrity, and availability.
The weakness was disclosed 07/19/2022 as Oracle Critical Patch Update Advisory - July 2022. The advisory is shared at oracle.com. The identification of this vulnerability is CVE-2021-42575. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 04/18/2025).
We expect the 0-day to have been worth approximately $25k-$100k. The vulnerability scanner Nessus provides a plugin with the ID 234557 (Oracle Essbase Multiple Vulnerabilities (April 2025 CPU)), which helps to determine the existence of the flaw in a target environment.
Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the vulnerability database at Tenable (234557). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 9.8VulDB Meta Temp Score: 9.6
VulDB Base Score: 9.8
VulDB Temp Score: 9.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 9.8
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Input validationCWE: CWE-20
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 234557
Nessus Name: Oracle Essbase Multiple Vulnerabilities (April 2025 CPU)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Timeline
10/18/2021 🔍07/19/2022 🔍
07/19/2022 🔍
07/20/2022 🔍
04/18/2025 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - July 2022
Status: Confirmed
CVE: CVE-2021-42575 (🔍)
GCVE (CVE): GCVE-0-2021-42575
GCVE (VulDB): GCVE-100-204377
Entry
Created: 07/20/2022 08:16Updated: 04/18/2025 05:30
Changes: 07/20/2022 08:16 (39), 08/13/2022 13:12 (2), 08/13/2022 13:19 (19), 04/18/2025 05:30 (16)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.